Profile
| Metric | Value |
|---|---|
| Full Name | CRISPR Therapeutics AG |
| Ticker | NASDAQ: CRSP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Switzerland |
| IPO | |
| Indexes | Not included |
| Website | crisprtx.com |
| Employees | 393 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $48.74 | |
| Price, 1D Change | +6.23% | |
| $5B | ||
| - | ||
| - | ||
| 1.31 | ||
| $37M | ||
| Revenue, 1Y Change | -89.95% | |
| -$4.34 | ||
| EPS, 1Y Change | -123.91% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.34 | ||
| EPS Estimate | -$6.19 | |
| EPS Est. Change | -42.58% | |
| $37.31M | ||
| Revenue Estimate | $6.12M | |
| Revenue Est. Change | -83.59% | |
| Current Price | $48.74 | |
| Price Target | - | $77.00 |
| Price Tgt. Change | - | +57.98% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.99 | -$1.94 | +35.15% | |
| -$5.12 | -$4.34 | +15.15% | |
| -$6.19 | N/A | -42.58% | |
| -$4.42 | N/A | -1.80% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $298.71M | $371.21M | +24.27% | |
| $13.93M | $37.31M | +167.84% | |
| $6.12M | N/A | -83.59% | |
| $122.94M | N/A | +229.47% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $48.74 | |
| $53.60 | ||
| SMA 200 vs Price | +9.98% | |
| $54.69 | ||
| SMA 50 vs Price | +12.20% | |
| 1.31 | ||
| $3.08 | ||
| 41.00 | ||
| 67.66% | ||
| 64.36% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $37.31M | ||
| -$4.34 | ||
| -$75.25M | ||
| -215.00% | ||
| -$466.57M | ||
| -1,250.38% | ||
| -$366.25M | ||
| -981.54% | ||
| -$447.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.12 | ||
| 22.07 | ||
| 22.07 | ||
| - | ||
| 2 | ||
| 8.46 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 121.16 | ||
| 2.42 | ||
| -6.39 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.93B | ||
| $298.26M | ||
| $2.24B | ||
| $1.94B | ||
| $309.95M | ||
| $87.78M | ||
| $223.69M | ||
| $17.29M | ||
| $14.71M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $501.57M | ||
| $391.32M | ||
| $110.25M | ||
| $72.98M | ||
| $19.26M | ||
| $0.00 | ||
| $3.59M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$142.77M | ||
| -$280.48M | ||
| $331.98M | ||
| $1.90M | ||
| -$144.68M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citizens | → | |
| Needham | → | |
| Citizens | → | |
| Chardan Capital | → | |
| Citigroup | → | |
| RBC Capital | → | |
| Baird | → | |
| Needham | → | |
| B of A Securities | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with CRSP
FAQ
What is the ticker symbol for CRISPR Therapeutics AG?
The ticker symbol for CRISPR Therapeutics AG is NASDAQ:CRSP
Does CRISPR Therapeutics AG pay dividends?
No, CRISPR Therapeutics AG does not pay dividends
What sector is CRISPR Therapeutics AG in?
CRISPR Therapeutics AG is in the Healthcare sector
What industry is CRISPR Therapeutics AG in?
CRISPR Therapeutics AG is in the Biotechnology industry
What country is CRISPR Therapeutics AG based in?
CRISPR Therapeutics AG is headquartered in Switzerland
When did CRISPR Therapeutics AG go public?
CRISPR Therapeutics AG initial public offering (IPO) was on October 19, 2016
Is CRISPR Therapeutics AG in the S&P 500?
No, CRISPR Therapeutics AG is not included in the S&P 500 index
Is CRISPR Therapeutics AG in the NASDAQ 100?
No, CRISPR Therapeutics AG is not included in the NASDAQ 100 index
Is CRISPR Therapeutics AG in the Dow Jones?
No, CRISPR Therapeutics AG is not included in the Dow Jones index
When was CRISPR Therapeutics AG last earnings report?
CRISPR Therapeutics AG's most recent earnings report was on November 10, 2025
When does CRISPR Therapeutics AG report earnings?
The next expected earnings date for CRISPR Therapeutics AG is February 18, 2026
Data Sources & References
- CRSP Official Website www.crisprtx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1674416/000119312525273337/0001193125-25-273337-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1674416/000095017025017899/0000950170-25-017899-index.htm
- CRSP Profile on Yahoo Finance finance.yahoo.com/quote/CRSP
- CRSP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crsp